Upload
mohammad-hadi-farjoo-md-phd
View
2.111
Download
2
Embed Size (px)
DESCRIPTION
The underlined words are hyperlinks; please click on them to see the whole presentation.Please tell me what you think about my slides, you can write to: [email protected]
Citation preview
Pharmacogenetics&
Pharmacogenomics
By
M.H.Farjoo M.D. , Ph.D.Shahid Beheshti University of Medical Science
Patient’s responseto drug
Diagnosis
Interactions with
concomitant drugs
Dose
Compliance
Genetic differences among patients
Response to Medicine
Sources of Pharmacokinetic and Pharmacodynamic Variability
Drug Specific:Dose & Schedule
Dosage formMorphometric:Body SizeBody Composition
Genetics:
Environment:Drug-drug interactions
Drug-CAM interactionsDrug-formulation interactions
Drug-food constituent interactions
Physiologic:DiseaseHepatic FunctionRenal Function
Demographic:AgeRace/EthnicitySex
Variability
Non-Responders and Patients Experiencing
Severe Toxicity
All patients with same diagnosis
Responders and Patients not Experiencing
Severe Toxicity
Definition
people respond differently to medicines due to their genetic inheritance.
Pharmacogenetics: study of genetically determined interindividual differences in response to drugs
Pharmacogenomics: use of genome based techniques in drug development
The Goals
Medicines do not have the same effect on everyone.
Some people do not respond at all, while others experience severe side effects.
Genetic factors account for some of these differences.
Recent research has suggested that 85% of patient responses to a drug are due to genetic factors.
The Goals
Pharmacogenetic determines:
How genetic make-up affects a drug effect. what side effects are likely to occur. Whether patients get the right drugs at the right dose.
scientists are trying:
to identify which genotypes respond to particular medicines.
To “personalise” medicines so that each drug has the desired effect on each person who uses it.
The Goals
Personalized Medicine: The Right Drug for the Right Patient at the Right Time
Pharmacogenetics The human genome contains 3 billion nucleotides
and the genomes of any 2 individuals vary in 3 million of them.
It is no surprise, then, that individuals have different responses to the same medicine.
Differences in our genes can affect drug absorption, distribution, metabolism and excretion.
Single Nucleotide Polymorphisms (SNPs or snips)
SNPs involve variations in single base pairs
This may not cause a change in amino acid sequence of a protein
But it may cause changes in the levels of its transcription or translation which affects response to a drug.
The aim is to identify SNPs determining which parts of the genome are relevant to drug response and to adverse reactions.
Succinylcholine Succinylcholine is used in surgery and some
patients suffer from prolonged paralysis.
Succinylcholine is broken down by an enzyme (Pseudocholinesterase).
The gene which codes for this enzyme is polymorphic.
The affected patients had a gene which coded for a different enzyme not capable of normal breakdown of acetylcholine.
Lymphoblastic Leukaemia
Mercaptopurine is used to treat lymphoblastic leukaemia in children.
It is broken down by an enzyme whose level is controlled by a single gene.
Homozygous people produce either very high or very low quantities of the enzyme.
Heterozygous people produce intermediate quantities of the enzyme.
Lymphoblastic Leukaemia
Lymphoblastic Leukaemia
Normal doses of mercaptopurine in homozygous negative patients can cause myelosuppression
The level of the enzyme can be measured using a simple blood test
this was one of the first pharmacogenetic tests in clinical use.
Alzheimer’s disease Sufferers have variations in the presence of
apolipoprotein E.
These differences predict not only the onset of the disease but also give clues for the treatment.
A drug can be given which slows progression in patients who do not have 2 copies of the gene for this protein.
Asthma bronchodilators are used for asthma but not
everyone responds in the same way.
>50% of the variance in response is due to genetic difference.
The drug that acts on bronchial smooth muscle has a target protein.
Some patients make a variant of this protein and cannot benefit from this form of treatment.
Techniques
Microarrays and Proteomics are used to identify how an individual’s genotype affects their response to a drug.
A microarray is a ‘chip’ which contains an array of DNA or RNA sequences or proteins.
It determines the effect of a drug on gene expression or to identify target genes for drug activity (i.e. to ‘design’ drugs).
Techniques
Proteomics is the study of all the proteins being expressed in a cell at a given time.
It can be used to help to identify which proteins may be good targets for drugs.
SummaryIn English
Thank youAny question?